HER2/NEU NEGATIVE
Clinical trials for HER2/NEU NEGATIVE explained in plain language.
Never miss a new study
Get alerted when new HER2/NEU NEGATIVE trials appear
Sign up with your email to follow new studies for HER2/NEU NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could some breast cancer patients avoid surgery?
Disease control Recruiting nowThis study is testing if breast cancer patients who respond exceptionally well to initial drug therapy can safely skip surgery or radiation. It is for women with early-stage breast cancer where a special biopsy shows no cancer remains after the drug treatment. The goal is to see …
Matched conditions: HER2/NEU NEGATIVE
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for when standard breast cancer drugs stop working
Disease control Recruiting nowThis study is testing two new drug combinations for people with advanced, BRCA-positive breast cancer that has spread and has stopped responding to a standard type of targeted therapy (PARP inhibitors). The trial will see if adding a second drug to the standard one can shrink tum…
Matched conditions: HER2/NEU NEGATIVE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC